GSK Aktie
18,55
EUR
+0,15
EUR
+0,82
%
17,03
CHF
-0,91
CHF
-5,08
%
Werbung
GSK Aktie Analyse
| 01.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.03.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.03.22 | GSK Neutral | UBS AG | |
| 28.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.02.22 | GSK Neutral | UBS AG | |
| 21.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.02.22 | GSK Neutral | UBS AG | |
| 18.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 10.02.22 | GSK Underperform | Credit Suisse Group | |
| 09.02.22 | GSK Neutral | UBS AG | |
| 09.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 28.01.22 | GSK Equal Weight | Barclays Capital | |
| 27.01.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | GSK Equal Weight | Barclays Capital | |
| 17.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | GSK Neutral | UBS AG | |
| 17.01.22 | GSK Underperform | Credit Suisse Group | |
| 13.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.01.22 | GSK Buy | Goldman Sachs Group Inc. | |
| 04.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.12.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 15.12.21 | GSK Buy | Jefferies & Company Inc. | |
| 14.12.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 07.12.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 07.12.21 | GSK Buy | Jefferies & Company Inc. | |
| 03.12.21 | GSK Hold | Deutsche Bank AG | |
| 30.11.21 | GSK Neutral | UBS AG | |
| 24.11.21 | GSK Neutral | UBS AG | |
| 23.11.21 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.11.21 | GSK Neutral | UBS AG | |
| 22.11.21 | GSK Neutral | UBS AG | |
| 11.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 10.11.21 | GSK Neutral | UBS AG | |
| 08.11.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 08.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.11.21 | GSK Neutral | UBS AG | |
| 05.11.21 | GSK Equal Weight | Barclays Capital | |
| 01.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.21 | GSK Hold | Deutsche Bank AG | |
| 28.10.21 | GSK Neutral | UBS AG | |
| 28.10.21 | GSK Hold | Kepler Cheuvreux | |
| 28.10.21 | GSK Underperform | Credit Suisse Group | |
| 28.10.21 | GSK Underweight | Barclays Capital | |
| 27.10.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 27.10.21 | GSK Buy | Jefferies & Company Inc. | |
Werbung
Werbung